Research Article

Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy

Table 2

Relationships between FGF-23 and clinical parameters.

VariableBaselineDay 53 months
Beta valueBeta-valueBeta value

FGF-23
 Cr0.01610.4020.01620.4000.150.02150.331
 Ca (mg/dL)0.09490.0400.09820.0360.15280.008
 P (mg/dL)0.00010.9490.00380.6870.00060.874
 iPTH (pg/ml)0.00980.5140.01210.4680.00750.567
 25(OH)D3 (ng/mL)0.090.00870.5380.070.00490.6450.220.04880.140
 ALP (U/L)0.150.02170.4140.270.07140.1330.240.05890.174
 Bone-ALP (μg/L)0.230.05210.4130.310.09900.2530.070.00530.797
 CaxP (mg2/dL2)0.0080.5560.0180.3750.01560.413
 Cr0.03550.2100.03140.2380.200.04150.174
 Ca (mg/dL)0.04400.1670.04870.1450.10020.034
 P (mg/dL)0.00800.5590.00010.9490.110.01290.458
 iPTH (pg/ml)0.00180.7780.00970.5150.00440.661
 25(OH)D3 (ng/ml)0.00630.6000.00580.6150.120.01530.413
 ALP (U/L)0.01500.4970.250.06260.1600.180.03390.305
 Bone-ALP (μg/L)0.02160.6010.250.06420.3620.00590.786
 CaxP (mg2/dL2)0.030.00070.8590.00410.6770.020.00030.903